Astrana Health Inc. Ordinary Shares ASTH 深 滬
已收盤 07-18 16:00:00 美东时间
22.65
-2.040
-8.26%
華盛通- 最 高24.93
- 今 開24.93
- 成交量 44.91万股
- 最 低 22.58
- 昨 收 24.69
- 總市值 11.31亿
- 52周最高 63.20
- 市盈率 靜 25.18
- 換手率 0.00%
- 52周最低 22.58
- 委 比 94.23%
- 總股本 4992.89万
- 歷史最高 123.51
- 量 比 1.41
- 振 幅 9.52%
- 歷史最低 9.27
- 每 手 1
- 風險率 7.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and Centene (CNC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
07-12 06:30
Astrana Health Announces Closing of Prospect Health Acquisition
ALHAMBRA, Calif., July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric...
07-02 19:00
Astrana Health Approves 2024 Equity Incentive Plan
Astrana Health ( ($ASTH) ) has shared an update. Astrana Health, Inc. held its ...
06-12 04:56
Astrana Health Updates Corporate Presentation Disclosure
Astrana Health ( ($ASTH) ) has shared an announcement. On May 13, 2025, Astrana...
05-14 05:06
Astrana Health shares are trading lower after the company reported worse-than-expected Q1 financial results.
Astrana Health shares are trading lower after the company reported worse-than-e...
05-10 01:11
Astrana Health Q1 EPS $0.14 Misses $0.23 Estimate, Sales $620.39M Miss $630.68M Estimate
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.23 by 39.13 percent. This is a 54.84 percent decrease over earnings of $0.31 per share from
05-09 04:24
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
Astrana Health (ASTH) Receives a Buy from Truist Financial
Truist Financial analyst Jailendra Singh reiterated a Buy rating on Astrana Hea...
04-20 21:56
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.
04-08 22:58
美股大行评级 | 潜在涨幅4159%！HC Wainwright & Co.上调BiomX目标价至21美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1114111385008877568.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BiomX(PHGE)"买入"评级，目标价从2美元升至21美元</p> <p>• HC Wainwright & Co.：维持Unicycive Therapeu
04-02 09:42
